8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.
Shield Your Body
Cancer & Tumors

Geng D, Liu A, Yan Y, Zheng W

Bioeffects Seen

Authors not listed · 2025

Share:

Genetic variants can alter how viruses behave in cells, revealing cancer mechanisms relevant to environmental exposures.

Plain English Summary

Summary written for general audiences

Researchers conducted the largest genetic study of nasopharyngeal carcinoma (NPC), analyzing nearly 14,000 people to identify genetic variants that increase cancer risk. They found three key genetic changes that make people more susceptible to this throat cancer, with one variant affecting how Epstein-Barr virus (EBV) behaves in cells. The study reveals how genetics and viral infections work together to cause this cancer.

Why This Matters

While this groundbreaking genetic study doesn't directly examine EMF exposure, it provides crucial context for understanding cancer development that's highly relevant to EMF health research. The finding that genetic variants can modulate viral behavior in cells - specifically how the RPL14 variant affects EBV life cycles - offers important insights into cancer mechanisms that could apply to EMF-induced cellular stress. The reality is that cancer rarely results from a single cause, but rather from complex interactions between genetic susceptibility, environmental exposures, and other factors like viral infections.

What this means for you is that genetic predisposition may influence how your cells respond to environmental stressors, including EMF exposure. The study's emphasis on the tumor microenvironment and cellular communication pathways aligns with research showing EMF can disrupt cellular signaling and potentially create conditions favorable for cancer development. Understanding these genetic-environmental interactions becomes increasingly important as we're exposed to unprecedented levels of man-made electromagnetic radiation.

Exposure Information

Specific exposure levels were not quantified in this study.

Cite This Study
Unknown (2025). Geng D, Liu A, Yan Y, Zheng W.
Show BibTeX
@article{geng_d_liu_a_yan_y_zheng_w_ce4379,
  author = {Unknown},
  title = {Geng D, Liu A, Yan Y, Zheng W},
  year = {2025},
  doi = {10.1172/JCI182768},
  
}
DOI: 10.1172/JCI182768PubMed: 39744943

Quick Questions About This Study

The study identified three key variants: rs2276868 in the RPL14 gene, rs5361 in SELE, and rs1050462 in HLA-B. The RPL14 variant was most significant, affecting how Epstein-Barr virus behaves in cells and contributing to cancer development.
The RPL14 variant modulates the Epstein-Barr virus life cycle within cells, creating conditions that promote nasopharyngeal carcinoma development. This demonstrates how genetic changes can alter viral behavior and cellular responses in cancer-prone tissues.
EBV infection status mediates the polygenic risk for nasopharyngeal carcinoma. The virus interacts with genetic variants, particularly RPL14, to influence cancer development, showing how infections and genetics work together in cancer formation.
The SELE genetic variant modifies endothelial cell function, which affects blood vessel cells lining tissues. This modification facilitates nasopharyngeal carcinoma progression by altering the tumor microenvironment and cellular communication pathways.
The study developed a refined composite polygenic risk score that outperforms existing models for predicting NPC risk. However, cancer development involves complex interactions between genetics, infections, and environmental factors beyond single genetic tests.